These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1099979)

  • 1. Immunologic aspects of myasthenia gravis.
    Lisak RP
    Ann Clin Lab Sci; 1975; 5(4):288-93. PubMed ID: 1099979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
    Simpson JA
    Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune aspects of myasthenia gravis].
    Saraiva S
    Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(3):181-8. PubMed ID: 4932911
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymic remodeling associated with hyperplasia in myasthenia gravis.
    Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
    Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease.
    De Baets MH
    Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis.
    Schönbeck S; Padberg F; Hohlfeld R; Wekerle H
    J Clin Invest; 1992 Jul; 90(1):245-50. PubMed ID: 1634612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
    Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
    Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR
    J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological heterogeneity of autoimmune myasthenia gravis.
    Pal J; Rozsa C; Komoly S; Illes Z
    J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic disorders and myasthenia gravis: genetic aspects.
    Zelano G; Settesoldi D; Lino MM; Batocchi A; Evoli A; Tonali PA
    Ann Med; 1999 Oct; 31 Suppl 2():46-51. PubMed ID: 10574155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymus gland pathology in myasthenia gravis: cause or consequence?].
    Zaĭrat'iants OV; Vetshev PS; Khavinson VKh; Ippolitov IKh; Shakhova OV
    Sov Med; 1990; (8):18-25. PubMed ID: 2274814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies.
    Aiso S; Yoshida T; Watanabe M; Hibi T; Asakura H; Tsuchiya M; Tsuru S
    J Clin Lab Immunol; 1984 Mar; 13(3):137-9. PubMed ID: 6609240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.